The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2
Top Cited Papers
- 1 May 2002
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (9), 2310-2318
- https://doi.org/10.1200/jco.2002.09.023
Abstract
PURPOSE: The morphologic and molecular phenotype of breast cancers may help identify patients who are likely to carry germline mutations in BRCA1 and BRCA2. This study evaluates the immunohistochem...Keywords
This publication has 33 references indexed in Scilit:
- The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutationsCancer, 1998
- Pathobiologic characteristics of hereditary breast cancerHuman Pathology, 1998
- Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 MutationsJNCI Journal of the National Cancer Institute, 1998
- BRCA-associated breast cancer in young women.Journal of Clinical Oncology, 1998
- Inherited BRCA2 mutation associated with high grade breast cancerBreast Cancer Research and Treatment, 1998
- Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish womenCancer, 1997
- Brca2 hereditary breast cancer pathophenotypeBreast Cancer Research and Treatment, 1997
- Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic casesThe Lancet, 1997
- Tumour biological features of BRCA1-induced breast and ovarian cancerEuropean Journal of Cancer, 1997
- Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkageCancer, 1996